<DOC>
	<DOC>NCT00367094</DOC>
	<brief_summary>This study will evaluate efficacy and safety data for benazepril/hydrochlorothiazide in adult Chinese patients with mild to moderate essential hypertension. Patients whose blood pressure is not adequately controlled with benazepril monotherapy during a 4 week run-in period will be randomly allocated to double blind treatment over 8 weeks with either a combination of benazepril/hydrochlorothiazide per day or continuation of benazepril per day.</brief_summary>
	<brief_title>Combination of Benazepril Plus Hydrochlorothiazide in Chinese Patients With Mild to Moderate Essential Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Benazepril</mesh_term>
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<criteria>Male or female patients, age 18 or older Given informed consent Diagnosed as having mild to moderate essential hypertension Severe hypertension Significant preexisting cardiovascular and cerebrovascular disease Diabetes mellitus type 1 or poorly controlled diabetes mellitus type II Advanced renal impairment Other protocoldefined inclusion/exclusion criteria may apply.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2007</verification_date>
	<keyword>Hypertension, benazepril, hydrochlorothiazide, fixed combination</keyword>
</DOC>